Alger Small Cap Focus Fund Class Z (AGOZX)

Overview

The fund is an investment entity that primarily focuses on allocating at least 80% of its net assets, along with any borrowed funds, towards purchasing equity securities. These securities are specifically of companies whose total market capitalization falls within the range of the Russell 2000 Growth Index at the time of the securities' acquisition. The Russell 2000 Growth Index itself is recognized as a broad-spectrum index, predominantly encompassing stocks of small capitalization. By channeling investments into companies within this index, the fund seeks to tap into the growth potential of small cap stocks, which often offer higher growth possibilities compared to their larger counterparts. This strategy is aimed at investors looking to potentially enhance their portfolio growth through exposure to this dynamic segment of the market.

Products and Services

• Equity Securities of Small-Cap Companies

This service involves the fund investing a substantial portion of its assets in the equity securities of companies classified within the small capitalization range of the Russell 2000 Growth Index. By targeting small-cap companies, the fund aims to leverage the growth potential inherent in this market segment, offering investors an opportunity to participate in the expected upward trajectory of these firms. The selection of these companies is grounded in their market capitalization at the time of the purchase, adhering to a strategy that prioritizes growth within the small-cap spectrum.

• Investment in Technology Companies

Accentuating its investment strategy, the fund dedicates at least 25% of its total assets towards technology companies, with a particular emphasis on those operating within the realms of medicine and information technology. This focused investment approach is designed to capitalize on the rapid advancements and innovation within the tech sector, especially in areas that have a significant impact on societal progress and well-being. By investing in medical and information technology companies, the fund not only seeks to benefit from the sector's growth prospects but also aligns itself with forward-thinking industries poised for substantial future development.